In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.

A-56619 and A-56620 are two new aryl-fluoroquinolones which are as potent as or more potent than norfloxacin when administered orally and subcutaneously in mouse protection tests against Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae. A-56619 and A-56620 were more potent...

Popoln opis

Bibliografske podrobnosti

izdano v:	Antimicrob Agents Chemother
Principais autores:	Fernandes, P B, Chu, D T, Bower, R R, Jarvis, K P, Ramer, N R, Shipkowitz, N
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1986
Teme:	Research Article
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176377/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3521473/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.29.2.201
Oznake:	Označite Brez oznak, prvi označite!